Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesa Laboratories (MLAB)
NASDAQ:MLAB
Mesa Laboratories (MLAB) Stock Price & Analysis
71 Followers
MLAB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$82.59 - $177.64
Previous Close$99.62
Volume31.08K
Average Volume (3M)45.23K
Market Cap
$537.36M
Enterprise Value$742.10M
Total Cash (Recent Filing)$28.22M
Total Debt (Recent Filing)$232.97M
Price to Earnings (P/E)568.6
Beta0.88
Next Earnings
May 24, 2024EPS Estimate
$1.91Next Dividend Ex-Date
May 31, 2024Dividend Yield0.63%
Share Statistics
EPS (TTM)0.17
Shares Outstanding5,394,051
10 Day Avg. Volume34,356
30 Day Avg. Volume45,225
Standard Deviation0.11
R-Squared0.17
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-3.14
Price to Sales (P/S)2.49
Price to Cash Flow (P/CF)12.00
P/FCF Ratio11.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.26
Enterprise Value/Gross Profit3.81
Enterprise Value/Ebitda26.00
Forecast
1Y Price Target
$124.00Price Target Upside24.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Mesa Laboratories News
PremiumCompany Announcements
Mesa Laboratories Enhances Financial Structure and Reduces Debt
PremiumPress Releases
MESA LABS DECLARES QUARTERLY DIVIDEND
PremiumPress Releases
Mesa Labs Announces Third Quarter Results
Ownership Overview
11.95% Insiders
30.96% Mutual Funds
22.27% Other Institutional Investors
34.82% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
MLAB FAQ
What was Mesa Laboratories’s price range in the past 12 months?
Mesa Laboratories lowest stock price was $82.58 and its highest was $177.64 in the past 12 months.
What is Mesa Laboratories’s market cap?
Currently, no data Available
When is Mesa Laboratories’s upcoming earnings report date?
Mesa Laboratories’s upcoming earnings report date is May 24, 2024 which is in 35 days.
How were Mesa Laboratories’s earnings last quarter?
Mesa Laboratories released its earnings results on Feb 05, 2024. The company reported $2.02 earnings per share for the quarter, beating the consensus estimate of $1.787 by $0.233.
Is Mesa Laboratories overvalued?
According to Wall Street analysts Mesa Laboratories’s price is currently Undervalued.
Does Mesa Laboratories pay dividends?
Mesa Laboratories pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 0.63%. See more information on Mesa Laboratories dividends here
What is Mesa Laboratories’s EPS estimate?
Mesa Laboratories’s EPS estimate is $1.91.
How many shares outstanding does Mesa Laboratories have?
Mesa Laboratories has 5,394,051 shares outstanding.
What happened to Mesa Laboratories’s price movement after its last earnings report?
Mesa Laboratories reported an EPS of $2.02 in its last earnings report, beating expectations of $1.787. Following the earnings report the stock price went up 5.636%.
Which hedge fund is a major shareholder of Mesa Laboratories?
Among the largest hedge funds holding Mesa Laboratories’s share is Royce & Associates LLC. It holds Mesa Laboratories’s shares valued at 28M.
---
Mesa Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$124.00 (24.47% Upside)
$124.00 (24.47% Upside)
Hedge Fund Trend
Increased
By 110.4K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.05%
12-Months-Change
Fundamentals
Return on Equity
0.24%
Trailing 12-Months
Asset Growth
11.88%
Trailing 12-Months
Company Description
Mesa Laboratories
Mesa Laboratories, Inc. engages in the design, manufacture, and marketing of instruments and disposable products utilized in healthcare, pharmaceutical, food, and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection, Instruments, Cold Chain Monitoring, and Cold Chain Packaging. The Sterilization and Disinfection segment offers testing services, along with the manufacturing and marketing of biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. The Instrument segment manufactures and markets control instruments and disposable products. The Cold Chain Monitoring segment designs, develops, and markets systems which are used to monitor environmental parameters such as temperature, humidity, and differential pressure. The Cold Chain Packaging segment provides consulting services including compliance monitoring, packaging development, and validation or mapping of transport and storage containers, and thermal packaging products. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
---
MLAB Stock 12 Months Forecast
Average Price Target
$124.00
▲(24.47% Upside)
Technical Analysis
Best Analysts Covering MLAB
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+1.30%
reiterated a buy rating 2 months ago
Copying Vijay Kumar's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +1.30% per trade.
---